Register Login
Register to leave comments
  • News bot Aug. 10, 2026, 12:36 p.m.

    📋 THERAVANCE BIOPHARMA, INC. (TBPH) - Financial Results

    Filing Date: 2026-08-10

    Accepted: 2026-08-10 08:35:01

    Event Type: Financial Results

    Event Details:

    THERAVANCE BIOPHARMA, INC. (TBPH) Reports the reporting period Financial Results THERAVANCE BIOPHARMA, INC. (TBPH) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: (7,500
    • Net Income: 9467
    • EPS: Not disclosed
    • Cash and equivalents: 387657
      • expected in 2H 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Cash Equivalents Marketable Securities 387.66K 315.36K $72.30K +22.93%
    Current Assets Property Equipment Net 5.17K 5.89K $-726.00 -12.32%
    Current Assets Other Assets 25.18K 24.88K $297.00 +1.19%
    Liabilities And Shareholders Equity Other Long Term Liabilities 244.00 313.00 $-69.00 -22.04%
    Costs And Expenses Selling General Administrative 18.43K 31.90K $-13.47K -42.22%
    Costs And Expenses Loss From Operations 2.73K 17.76K $-15.04K -84.66%
    Selling, General & Administrative 3.56K 6.42K $-2.87K -44.62%
    Property and Equipment, Net 5.89K 5.89K $0.00 +0.00%
    Other Assets 24.88K 24.88K $0.00 +0.00%
    Operating Lease Liabilities 31.76K 31.76K $0.00 +0.00%
    Revenue 7.50K 7.50K $0.00 +0.00%
    Loss from Operations 2.73K 17.76K $-15.04K -84.66%
    Interest Expense 663.00 663.00 $0.00 +0.00%
    Interest Income 1.46K 6.50K $-5.04K -77.58%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: THERAVANCE BIOPHARMA, INC.
    • Ticker Symbol: TBPH

Search

News categories